Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.
Nathan CarberrySun YuRaisy N FayermanRachelle DugueMichael L MillerKurenai TanjiTarini GoyalPeter CanollThomas H BrannaganPublished in: The Neurohospitalist (2022)
A 31-year-old woman with transthyretin (TTR) amyloidosis secondary to a Thr60Ala mutation developed recurrent stroke-like episodes with fluctuating mental status. Evaluation for stroke and seizures was unrevealing. She was found to have leptomeningeal contrast enhancement on magnetic resonance imaging, which was confirmed to be CNS TTR amyloidosis on histopathology following brain and dura biopsy. While leptomeningeal disease has rarely been known to be associated with TTR amyloidosis, this is the first documented case of leptomeningeal disease secondary to a Thr60Ala mutation in the TTR gene. A literature review of TTR amyloidosis is presented with special focus on the treatment of leptomeningeal TTR amyloidosis.
Keyphrases
- cerebrospinal fluid
- multiple myeloma
- magnetic resonance imaging
- atrial fibrillation
- magnetic resonance
- computed tomography
- multiple sclerosis
- genome wide
- gene expression
- cerebral ischemia
- blood brain barrier
- wild type
- dna methylation
- ultrasound guided
- brain injury
- resting state
- subarachnoid hemorrhage
- genome wide identification